Inflammatory bowel disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 32: Line 32:
==Case Studies==
==Case Studies==
[[Inflammatory bowel disease case study one|Case #1]]
[[Inflammatory bowel disease case study one|Case #1]]
==References==
* Furrie, E. Biotic Therapy Cuts Inflammation in Ulcerative Colitis. Gut 2005;54:242-249.
* Kruis, W., P Fric, J Pokrotnieks, M Lukás, B Fixa, M Kascák, M A Kamm, J Weismueller, C Beglinger, M Stolte, C Wolff, and J Schulze. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-1623.
* Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R, Weinstock JV. ''Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.'' Am J Gastroenterol 2003;98:2034-41. PMID 14499784.
* Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. ''J. Exp. Med.'' 2006; '''203''':2473-2483. [http://www.jem.org/cgi/content/abstract/203/11/2473]


==External links==
==External links==

Revision as of 18:52, 29 November 2012